Unqualified Drugs: Major Pharmaceutical Companies Under Scrutiny

December 26, 2023

Recently, the news of 20 batches of unqualified drugs has attracted attention, and many well-known pharmaceutical companies have been listed. The announcement shows that 9 batches of drugs produced by Beijing Tongrentang Technology Development Co., Ltd., Qilu Pharmaceutical Co., Ltd., and other 9 companies were found to be unqualified after being tested by 9 drug testing institutions including the China National Institute for Food and Drug Control.


 

The marked production companies, drug names, and batch numbers of the unqualified products are as follows:

- The injection somatostatin produced by Shenzhen Hanyu Pharmaceutical Co., Ltd., with batch number 1123161204.

- The stomach-protecting tablets with batch number 20160701 produced by Changchun People's Pharmaceutical Group Co., Ltd.

- The liver nourishing capsules with batch number 151202 produced by Harbin Dayang Pharmaceutical Co., Ltd.

- The lipid-lowering granules with batch number 20160902 produced by Changchun Yinnuoke Pharmaceutical Co., Ltd.

- The chest-opening qi-regulating pills with batch number 15080858 produced by Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory.

- The musk bone-strengthening plaster with batch number 150903 produced by Chongqing Lingfang Sanfan Biopharmaceutical Co., Ltd.

- The protease particles for the stomach with batch number 161101 produced by Taikang Haien Pharmaceutical Co., Ltd.

- The vitamin E nicotinate capsules with batch number 1609231 produced by Duoduo Pharmaceutical Co., Ltd.

- The cephalothin for injection with batch number 5120108AE produced by Qilu Pharmaceutical Co., Ltd.

The unqualified items include appearance, content determination, disintegration time limit, weight difference, filling difference, ointment content, and potency determination.

The relevant provincial food and drug supervision and management departments have taken control measures such as sealing and confiscation for the above-mentioned unqualified drugs, requiring companies to suspend sales and use, recall products, and carry out rectification.

Share

Everyone Is Watching

icon

Hot Picks